lecithin-bound iodine

04/01/2005 - "Lecithin-bound iodine (LBI), which has been reported to be a potential candidate for one of the therapeutic modalities for children with bronchial asthma based on the in-vitro study, was also found to be effective in relieving the symptoms of patients with childhood asthma. "
04/01/2005 - "Effect of lecithin-bound iodine on the patients with bronchial asthma."
10/01/1965 - "[Clinical observation of the effectiveness of Jolethin in the treatment of asthma and eczema in infants and children]."
08/01/1995 - "2. Lecithin-bound iodine (LBI), with which children with bronchial asthma have been successfully treated in the range of 0.5 to 5 microM, concentrations comparable to LBI blood levels in medicated individuals, modified mite antigen-induced immune responses, thereby decreasing abnormal lymphocyte functions. "
08/01/1995 - "Modulation of mite antigen-induced immune responses by lecithin-bound iodine in peripheral blood lymphocytes from patients with bronchial asthma."

11/01/2021 - "Although lecithin-bound iodine (LBI) has been administered orally for retinal diseases, a lack of clinical studies and obscure action mechanism of LBI hinder its large-scale prescription. "

03/01/2023 - "To compare the effectiveness and safety of spironolactone versus lecithin-bound iodine in patients with central serous retinopathy (CSR). "

11/01/2021 - "Effect of Lecithin-Bound Iodine Treatment on Inherited Retinal Degeneration in Mice."

08/01/1981 - "[Effect of lecithin-bound iodine on allergic reaction and immune response (author's transl)]."